Michael Fossel and his biopharmaceutical company Telocyte claim[0] to have a novel, effective treatment for Alzheimers, one that does not simply target the amyl

Michael Fossel and his biopharmaceutical company Telocyte claim[0] to have a novel, effective treatment for Alzheimers, one that does not simply target the amyloid and tau pathways. Telocyte's treatment is based on telomerase gene therapy, and is currently undergoing FDA safety trials. According to Fossel, their telomerase gene therapy reverses cognitive decline in animal models, and they're confident the same will apply to humans. Human trials begin in 2018. I wonder whether Gates has seen Telocyte's work. [0]: http://www.michaelfossel.com/blog/?p=249 http://www.michaelfossel.com/blog/?p=249